Hellow guys, Welcome to my website, and you are watching Quality control in manufacturing CAR-T cell therapies. and this vIdeo is uploaded by VJHemOnc – Video Journal of Hematology & HemOnc at 2022-04-14T08:55:33-07:00. We are pramote this video only for entertainment and educational perpose only. So, I hop you like our website.
| Name | Quality control in manufacturing CAR-T cell therapies |
| Video Uploader | Video From VJHemOnc – Video Journal of Hematology & HemOnc |
| Upload Date | This Video Uploaded At 14-04-2022 15:55:33 |
| Video Discription | Saskia Rösch, PhD, Miltenyi Biotec, Bergisch Gladbach, Germany, describes methods to directly detect and isolate chimeric antigen receptor (CAR) derived from patient samples, including a CAR detection agent that enables the measurement of the transduction rate and presence of active CARs. The system can currently detect CD19, CD22, CD33, and B-cell maturation antigen (BCMA). Dr Rösch additionally highlights further tools to monitor the metabolome of CAR T-cells, which can be utilized in monitoring patient response. This interview took place at the International Conference on Lymphocyte Engineering (ICLE) 2022. |
| Category | Education |
| Tags | Speaker: Saskia Rösch | Institution: Miltenyi Biotec | Event: ICLE 2022 | Format: Interview | Subject: General | Field: CAR-T & Cellular Therapy | Medicines: CAR-T | manufacturing | quality control | CAR | CD19 | CD22 | CD33 | B-cell maturation antigen | BCMA | metabolome | transduction |
